Quantitative Assessment of Promoter Hypermethylation during Breast Cancer Development
- 1 February 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 160 (2) , 605-612
- https://doi.org/10.1016/s0002-9440(10)64880-8
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (Fe 516/1-1)
This publication has 43 references indexed in Scilit:
- Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancerOncogene, 2001
- Methylation mattersJournal of Medical Genetics, 2001
- Methylation of the p16Ink4a tumor suppressor gene 5′-CpG island in breast cancerCancer Letters, 2001
- Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinomaOncogene, 2000
- Detection of Gene Amplification in Archival Breast Cancer Specimens by Laser-Assisted Microdissection and Quantitative Real-Time Polymerase Chain ReactionThe American Journal of Pathology, 2000
- The Hallmarks of CancerCell, 2000
- Methylation-Induced Repression— Belts, Braces, and ChromatinPublished by Elsevier ,1999
- DNA methylation and chromatin modificationCurrent Opinion in Genetics & Development, 1999
- Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissueOncogene, 1998
- Advances in quantitative PCR technology: 5′ nuclease assaysCurrent Opinion in Biotechnology, 1998